Early Release / Consensus Report
Use of the BioFire® FilmArray® Pneumonia Plus Rapid Syndromic Multiplex PCR Assay in Pneumonia Patients – An Expert Opinion Report
Most Read
Abstract
Objective: In regions where Crimean-Congo hemorrhagic fever (CCHF) and acute brucellosis are endemic, a diagnostic dilemma arises in patients who present to the emergency department with high fever and are diagnosed with leukopenia and thrombocytopenia. This study aimed to compare the clinical, epidemiological, and laboratory features of CCHF and acute brucellosis cases, revealing their similarities and differences, thereby guiding clinicians, especially those performing initial evaluations, in the differential diagnosis process.
Methods: Crimean-Congo hemorrhagic fever and acute brucellosis cases diagnosed in our center between June 2013 and June 2023 were evaluated retrospectively. Crimean-Congo hemorrhagic fever diagnosis was confirmed by RT-PCR test, while acute brucellosis diagnosis was made by blood culture and/or serological tests. Only the first application of each patient was included in the study. Demographic information and clinical and laboratory findings of the cases were obtained from patient files.
Results: A total of 88 patients with CCHF and 95 patients with acute brucellosis were included in the study. No statistically significant differences were found between the groups in terms of age, gender, rural residence, or occupation (p>0.05). In CCHF patients, leukopenia, thrombocytopenia, and elevated levels of creatine phosphokinase (CPK), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) were significantly more common (p<0.001). In cases of acute brucellosis, anemia, erythrocyte sedimentation rate, and C-reactive protein (CRP) levels were significantly higher (p<0.001). Measurements above the threshold value of 277 U/L determined for CPK provided 88.64% sensitivity and 90.53% specificity in predicting the diagnosis of CCHF (AUC=0.953). Conjunctival hyperemia, nausea, vomiting, and diarrhea were more common in CCHF patients, while back pain, hip pain, and widespread joint pain were more prominent in acute brucellosis patients.
Conclusion: Certain clinical and laboratory findings obtained at the initial presentation of patients with CCHF and acute brucellosis may aid the clinician in making a diagnostic distinction. In particular, it has been observed that the CPK level has high diagnostic value in distinguishing between these two diseases. Multicenter studies with larger samples that will represent the whole country are needed.
References
- Rekik S, Hammami I, Timoumi O, et al. A review on Crimean-Congo hemorrhagic fever infections in Tunisia. Vector Borne Zoonotic Dis. 2024;24(6):325-37. [CrossRef]
- Eslava M, Carlos S, Reina G. Crimean-Congo hemorrhagic fever virus: An emerging threat in Europe with a focus on epidemiology in Spain. Pathogens. 2024;13(9):770. [CrossRef]
- Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6(12):e1929. [CrossRef]
- Amjadi O, Rafiei A, Mardani M, Zafari P, Zarifian A. A review of the immunopathogenesis of brucellosis. Infect Dis (Lond). 2019;51(5):321-33. [CrossRef]
- Qie C, Cui J, Liu Y, Li Y, Wu H, Mi Y. Epidemiological and clinical characteristics of bacteremic brucellosis. J Int Med Res. 2020;48(7):300060520936829. [CrossRef]
- Heydari AA. Acute complicated brucellosis mimicking Crimean-Congo hemorrhagic fever (CCHF) and vice versa. J Med Microbiol. 2019;7(1-2):1-5. [CrossRef]
- Duygu F, Sari T, Kaya T, Bulut N. Brucellosis in patients with Crimean-Congo hemorrhagic fever. J Arthropod Borne Dis. 2017;11(4):463-8.
- Almiş H, Yakıncı C. [A case of brucellosis misdiagnosed as Crimean-Congo hemorrhagic fever]. Mikrobiyol Bul. 2012;46(3):475-9. Turkish.
- Metin O, Teke TA, Gayretli Aydin ZG, et al. A case of brucellosis mimicking Crimean-Congo hemorrhagic fever. J Infect Public Health. 2015;8(3):302-4. [CrossRef]
- Yilmaz GR, Buzgan T, Torunoglu MA, et al. A preliminary report on Crimean-Congo haemorrhagic fever in Turkey, March – June 2008. Euro Surveill. 2008;13(33):18953. [CrossRef]
- Jääskeläinen AJ, Kallio-Kokko H, Ozkul A, et al. Development and evaluation of a real-time RT-qPCR for detection of Crimean-Congo hemorrhagic fever virus representing different genotypes. Vector Borne Zoonotic Dis. 2014;14(12):870-2. [CrossRef]
- Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2019;33(1):e00073-19. [CrossRef]
- Al Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis–a review of the literature. Part II: serological tests for brucellosis. Clin Lab. 2003;49(11-12):577-89.
- Uysal B, Mumcu N, Yıldız O, Aygen B. [Comparison of the methods used in the diagnosis of brucellosis]. Klimik Derg. 2021;34(3):164-73. Turkish. [CrossRef]
- Gaifer Z, Ali MEM, AlJehani BH, Shaikh HA, Hussein SB. Risk factors, outcomes and time to detect positive blood culture among cases with acute brucellosis. Trans R Soc Trop Med Hyg. 2022;116(2):133-8. [CrossRef]
- Shi Y, Gao H, Pappas G, et al. Clinical features of 2041 human brucellosis cases in China. PLoS One. 2018;13(11):e0205500. Erratum in: PLoS One. 2019;14(1):e0211102. Erratum in: PLoS One. 2019;14(3):e0213558. Erratum in: PLoS One. 2019;14(6):e0219110. [CrossRef]
- Mourya DT, Viswanathan R, Jadhav SK, Yadav PD, Basu A, Chadha MS. Retrospective analysis of clinical information in Crimean-Congo haemorrhagic fever patients: 2014-2015, India. Indian J Med Res. 2017;145(5):673-8. [CrossRef]
- Fillâtre P, Revest M, Tattevin P. Crimean-Congo hemorrhagic fever: An update. Med Mal Infect. 2019;49(8):574-85. Erratum in: Med Mal Infect. 2020;50(1):
95-6. [CrossRef] - Zheng R, Xie S, Lu X, et al. A Systematic review and meta-analysis of epidemiology and clinical manifestations of human brucellosis in China. Biomed Res Int. 2018;2018:5712920. [CrossRef]
- Gürbüz E, Ekici A, Ünlü AH, Yılmaz H. Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever. Turk J Med Sci. 2021;51(4):1825-32. [CrossRef]
- Arslan M, Yılmaz G. [Investigation of hematological changes in patients with Crimean-Congo hemorrhagic fever]. GUJHS. 2023;12(2):437-42. Turkish. [CrossRef]
- Demir M, Duksal F, Doğan MT, et al. [Immunological evaluation of children with Crimean-Congo hemorrhagic fever in addition to routine clinical and laboratory tests who were admitted to Sivas, Cumhuriyet University]. J Curr Pediatr. 2015;13(1):13-20. Turkish. [CrossRef]
- Giambartolomei GH, Delpino MV. Immunopathogenesis of hepatic brucellosis. Front Cell Infect Microbiol. 2019;9:423. [CrossRef]
- Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6(4):203-14. [CrossRef]
- Arslan M, Yilmaz G, Mentese A, Yilmaz H, Karahan SC, Koksal I. Importance of endothelial dysfunction biomarkers in patients with Crimean-Congo hemorrhagic fever. J Med Virol. 2017;89(12):2084-91. [CrossRef]
- Parlak M, Akbayram S, Doğan M, et al. Clinical manifestations and laboratory findings of 496 children with brucellosis in Van, Turkey. Pediatr Int. 2015;57(4):586-9. [CrossRef]
- Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol. 2010;47(4):361-5. [CrossRef]
- Sari I, Bakir S, Engin A, Aydin H, Poyraz O. Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever. Bosn J Basic Med Sci. 2013;13(1):21-6. [CrossRef]
- Kitzenberg D, Colgan SP, Glover LE. Creatine kinase in ischemic and inflammatory disorders. Clin Transl Med. 2016;5(1):31. [CrossRef]
- Arslan M, Comoglu S. Evaluation of epidemiological, clinical, laboratory and treatment characteristics of Crimen Congo hemorrhagic fever patients: Results of a 10-year analysis. North Clin Istanb. 2024;11(3):177-83. [CrossRef]
- Hatipoglu CA, Bulut C, Yetkin MA, et al. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand J Infect Dis. 2010;42(6-7):516-21. [CrossRef]
- Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis. 2008;12(4):374-9. [CrossRef]